Checkpoint Therapeutics, Inc.
USD4.26
+0.00 (+0.00%)
CEO
James F. Oliviero III,
IPO Date
2016-12-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.24
Prev. Close
$4.26
Day Low
$4.24
Day High
$4.26
52W Low
$1.80
52W High
$4.50
Market Cap
$0.37B
Volume
8.63M
| 6,122,249 |
| $4.10 |
| 3 Jun 2025 | Fortress Biotech, Inc. | 10 percent owner | D-Return | Disposed | 700,000 | $4.10 |
| 30 May 2025 | WEISS MICHAEL S | director | A-Award | Acquired | 12,195 | $0.00 |
| 30 May 2025 | WEISS MICHAEL S | director | A-Award | Acquired | 50,000 | $1.29 |
| 30 May 2025 | WEISS MICHAEL S | director | U-Tender | Disposed | 187,007 | $4.10 |
| 30 May 2025 | SALZMAN BARRY M | director | A-Award | Acquired | 12,195 | $0.00 |
| 30 May 2025 | SALZMAN BARRY M | director | U-Tender | Disposed | 147,007 | $4.10 |
| 30 May 2025 | ROSENWALD LINDSAY A MD | director | A-Award | Acquired | 12,195 | $0.00 |
| 30 May 2025 | ROSENWALD LINDSAY A MD | director | A-Award | Acquired | 50,000 | $1.29 |